drugset / Trial / NCT04392063

Melatonin for Cerebral Palsy Children's Sleep and Health

NCT04392063

Completed 40 enrolled Ain Shams University
NaSingle-groupOpen-labelTreatment

Summary

The present study was prospective uncontrolled, single-armed and un-blinded study. Held in the Pediatric neurology clinic, Children's hospital l, Faculty of Medicine, Ain Shams University from June 2016 to June 2018 of 24 months timeframe. All cerebral palsy (CP) patients following up in Pediatric neurology clinic aged between 2 and 12 years. Melatonin given for 3 months. Anthropmetric measures, gastroeintestinal symptoms, Children's sleep habits questionnaire (CSHQ) Arabic version, polysomnography, Chalfont epilepsy severity score, and EEG were done at enrollment and after the 3-months.

Timeline

Start
2016-06
Primary completion
2018-06
Completion
2018-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 3 mg Oral

Indications